C. Dean Maglaris, CEO, Chairman of the Board of Managers. Mr. Maglaris is an experienced senior executive in the pharmaceutical industry, having spent over 33 years with Pfizer Inc. in leadership positions in marketing, product and business development and general management. His experience covered the spectrum of major therapeutic areas in pharmaceuticals plus a wide array of medical device markets in the U.S. and worldwide. As Group Vice President and General Manager, he was instrumental in the development and launch of several products that became major successes, with several achieving annual sales in excess of $1.0 billion each. Mr. Maglaris has been a member of a number of associations, including the Pharmaceutical Research and Manufacturers of America and the Biotechnology Industry Organization. He is a past Trustee and Chair of the Board of Trustees of the University of Vermont, a past member and officer of the Board of Trustees of the New Canaan Country School and serves as Chariman of the Board of Directors of the AmeriCares Foundation. He holds a B.S. degree from the University of Vermont and an MBA from Northeastern University.
Buck Griswold (E. Bulkeley Griswold), Managing Director, Senior Principal, Centripetal Capital Partners, has over 40 years of experience in investments. As Vice President of the Phoenix Mutual Life Insurance Company from 1970 to 1977, Mr. Griswold managed the administration and investment decisions for a $1.5 billion portfolio in public and private fixed income and equities. He subsequently joined General Electric Investment Company (GEIC), the internal investment management company for GE pension assets and other affiliated GE portfolios. Mr. Griswold was Executive Vice President Trustee responsible a $15 billion portfolio of assets including corporate and municipal bonds, private placements, real estate and short-term investments. From 1983 to 1998, Mr. Griswold was a part owner of Marketing Corporation of America (MCA), an integrated marketing services firm. He led the company's venture capital group as President and General Partner of MarketCorp Venture Associates, LP - a $66 million venture capital fund jointly formed with MCA. In 1998, he founded L&L Capital Partners, LLC to provide management consulting and financial advisory services to venture-backed companies. He received a BS at the University of Maryland and an MBA from University of Connecticut.
Joseph J. Rucci, Jr., serves as an outside manager on the Company's Board of Managers and is also a member of the Compensation Committee. Mr. Rucci is founder/member of the Rucci Law Group with offices in Connecticut. He concentrates in the areas of business law, banking and not-for-profit organizations. He is admitted to practice before the Connecticut Bar, the United States District Court for Connecticut and the United States Court of Appeals for the First Circuit, as well as the United States Supreme Court. He is a director and chairman of the Governance Committee of the AmeriCares Foundation, Inc.; a director of the Pear Tree Point School Foundation, Inc.; a member of Rotary International and of the Sovereign Order of Malta. Mr. Rucci has been recognized for his expertise by The Martindale Hubbell Bar Register of Preeminent Lawyers and the National Directory of Who's Who on Executives and Professionals. Mr. Rucci was awarded a Juris Doctorate from the Villanova University School of Law in 1966 and graduated from Fairfield University in 1963.
Frederick W. Telling, Ph.D., Prior to retiring from Pfizer in June 2007 after 30 years, Fred was elected a Corporate Vice President of Pfizer Inc and its Vice President of Corporate Strategic Planning and Policy in October 1994. He oversaw the company's realignment and focus on its human and animal health business - divesting its Food Science and Medical Technology groups, while acquiring Warner Lambert, Pharmacia and various consumer product brands. Concurrently, Fred was responsible for the company's policy development and he represented the company in many industry related outside Boards, including BIO where he served on its Board for over 10 years.
Dr. Telling is currently the Chairman of Oragenics in Tampa, Florida and a Director of Cell Therapeutics Inc. based in Seattle, Washington and Eisai N.A. Inc. in Woodcliff Lake, New Jersey. Fred chairs the Compensation Committee and serves on the Audit Committee of both Cell Therapeutics and Oragenics.
Dr. Telling is a member of the Board of the United Hospital Fund and an emeritus member of the Boards of several organizations with which he remains involved - the National March of Dimes Foundation, EAA, ORBIS, and the Smithsonian National Air & Space Museum. Fred is the President of the T-6 Racing Association and a member of The Metropolitan Club of Washington, DC.
Dr. Telling received his BA from Hamilton College and his Master's of Industrial and Labor Relations and Ph. D. in Economics and Public Policy from Cornell University.
Cassandra Klimp., An initial investor and a founding manager of Cytogel Pharma is a partner of Meridian Partners LLC, a technology venture advisory firm and the Classic Motorcar Investment Fund in Connecticut with 30 years of experience in corporate banking, project management and entrepreneurship. Early in her career she was affiliated with US Bancorp in Minneapolis as the corporate lender to multibank holding companies throughout the Midwest. She has performed a broad range of advisory, managerial, financial and project related functions both for profit and non-profit organizations. Ms. Klimp was a long time member of the board of Waveny Care Center and the New Canaan Historical Society. She co-chaired the planning and construction of a state of the art Alzheimer’s community at Waveny Care Center that received national recognition. She is a native of Minnesota and holds a BS and post graduate work in the sciences from the University of Minnesota